Veeva Systems Stock

Veeva Systems Market capitalization

The The market capitalization of Veeva Systems (VEEV) as of Sep 14, 2026 is 30.74 B USD. In the previous year, The market capitalization was 30.74 B USD — a change of 0.00% (lower).

Market capitalization

30.74 BUSD

YoY

0.00%

Last updated:

In 2026, Veeva Systems's market cap stood at 30.74 B USD, a 0.00% increase from the 30.74 B USD market cap in the previous year.

The Veeva Systems Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2019
30.74 B USD
Jan 1, 2020
30.74 B USD
Jan 1, 2021
30.74 B USD
Jan 1, 2022
30.74 B USD
Jan 1, 2023
30.74 B USD
Jan 1, 2024
30.74 B USD
Jan 1, 2025
30.74 B USD
Jan 1, 2026
30.74 B USD
The Veeva Systems Market capitalization history
YEARMarket capitalizationYoY
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD0.00%
30.74 BUSD
Access this data via the Eulerpool API

Veeva Systems Stock analysis

What does Veeva Systems do? The history of Veeva Systems Inc: Veeva Systems is a leading company in the field of cloud software for the life science industry. The company was founded in 2007 and is headquartered in Pleasanton, California. Veeva was created by Peter Gassner and Matt Wallach to improve the management of clinical trials and collaboration in the pharmaceutical industry. Business model of Veeva Systems Inc: The business model of Veeva Systems is focused on improving efficiency and collaboration in the life science industry. The company offers cloud-based software solutions tailored to the needs of life science companies. These solutions include CRM systems, clinical trial management software, data management tools, and analytics tools. Veeva Systems was founded as a CRM company for the life science industry. With its first software, Veeva CRM, the company revolutionized how pharmaceutical companies manage and collaborate with their sales forces. Since then, Veeva Systems has expanded its portfolio and offers a wide range of software solutions, ranging from planning and conducting clinical trials to collecting and analyzing data. Divisions of Veeva Systems Inc: Veeva Systems is divided into three divisions: 1) Commercial Cloud: This division of Veeva Systems provides software solutions for managing customer relationships, sales and marketing activities, and digital marketing for life science companies. 2) Vault: The Vault division of Veeva Systems offers software solutions for managing content, data, and processes involved in clinical trials and other research projects. 3) Data Cloud: This division offers analytics and data management tools that enable life science companies to collect, manage, and analyze their data. Products of Veeva Systems Inc: Veeva CRM: A CRM software solution that allows pharmaceutical companies to control and manage their sales and marketing activities. Veeva Vault: A suite of software solutions that facilitate the management of clinical trials and research projects. Vault provides solutions for electronic data capture, electronic informed consent forms (eICFs), clinical data management, and document management. Veeva Network: A cloud-based platform that enables life science companies to simultaneously collect patient data and advertise for it. Veeva OpenData: A database of contacts and companies from the life science industry that is regularly updated. Veeva Align: A tool for optimizing personnel deployment and ensuring compliance in the sales of life science companies. Veeva Vault QualityOne: A platform for managing quality control processes, including supply chain monitoring, compliance with regulations, and ensuring standards. Conclusion: Veeva Systems has positioned itself as a leading provider of cloud software solutions for the life science industry and offers its portfolio of CRM, clinical trial management, data management, and analytics tools. The company has succeeded in improving collaboration in the pharmaceutical industry by leveraging cloud technologies to increase effectiveness, safety, and compliance. Veeva Systems is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Veeva Systems's Market Capitalization

Veeva Systems's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Veeva Systems's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Veeva Systems's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Veeva Systems’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Veeva Systems stock

The market capitalization of Veeva Systems is 30.74 B USD in 2026.

The market capitalization of Veeva Systems changed from 30.74 B USD to 30.74 B USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Veeva Systems since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Veeva Systems with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Veeva Systems

All Key Metrics — Veeva Systems